SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Drugs
Drugs
Page 3 of 28
Aging Well
Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By
Lindsey Leake
February 6, 2025
Success
Bill Gates says Steve Jobs told him he should’ve taken acid as it would have made Microsoft’s products look better
By
Eleanor Pringle
February 6, 2025
Commentary
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By
Jeffrey Sonnenfeld
and
Steven Tian
February 5, 2025
Health
Patients will pay more for prescription meds and face drug shortages amid Trump tariffs, pharma groups warn
By
Lindsey Leake
February 5, 2025
Health
Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
By
Hallie Steiner
February 4, 2025
Health
Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential
By
Hallie Steiner
February 4, 2025
Health
Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines
By
Bloomberg
and
Damian Garde
February 4, 2025
Health
Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results
By
Ryan Hogg
February 4, 2025
Health
The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits
By
Lindsey Leake
February 4, 2025
Health
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By
Lindsey Leake
February 3, 2025
Health
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By
Bloomberg
and
Gerry Smith
January 31, 2025
Health
Cigna plans to limit out-of-pocket drug costs for U.S. patients
By
Bloomberg
and
John Tozzi
January 30, 2025
Health
Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By
Lindsey Leake
January 29, 2025
Mind
The truth about cannabis: Researchers from largest study on its effects on the brain have a warning for young adults
By
Lindsey Leake
January 28, 2025
Finance
Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise
By
Greg McKenna
January 24, 2025
Most Popular
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Tech
‘Yes, you read that correctly’: Tesla pay committee pitches $1 trillion pact to keep Elon Musk as CEO for long term
By
Nick Lichtenberg